GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth

Cancer Research

Volumn 64, Issue 7, 2004, Pages 2474-2481

  Zhang, Xiuwu ^a,c   Huang, Qian ^a,b   Yang, Zhonghui ^a   Li, Yongping ^a   Li, Chuan Yuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; HYDROGEN PEROXIDE; PROTEIN; PROTEIN GRIM 19; PROTEIN GW112; RETINOIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; STRESS;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; INTERFERON-BETA; MITOCHONDRIA; NADH, NADPH OXIDOREDUCTASES; TRETINOIN; UP-REGULATION;

EID: 1942538392     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3443     Document Type: Article

References (50)

1. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
2. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
3. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999;96:245-54.
4. Jacks T, Weinberg RA. Taking the study of cancer cell survival to a new dimension. Cell 2002;111:923-5.
5. Abrams JM. Competition and compensation: coupled to death in development and cancer. Cell 2002;110:403-6.
6. Coultas L, Strasser A. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 2003;13:115-23.
7. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003;3:193-202.
8. Folkman J Angiogenesis and apoptosis. Semin Cancer Biol 2003;13:159-67.
9. Yuan J, Yankner BA. Caspase activity sows the seeds of neuronal death. Nat Cell Biol 1999;1:E44-45.
10. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature (Lond) 2000;407: 802-9.
11. Nathan C. Points of control in inflammation. Nature 2002;420:846-852.
12. Stassi G, De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002;2:195-204.
13. Eguchi K. Apoptosis in autoimmune diseases. Intern Med 2001;40:275-84.
14. Cuconati A, Degenhardt K, Sundararajan R, Anschel A, White E. Bak and Bax function to limit adenovirus replication through apoptosis induction. J Virol 2002;76:4547-58.
15. Cuconati A, White E. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev. 2002;16:2465-78.
16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
17. Chau BN, Wang JY. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003;3:130-8.
18. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 2003;3:102-9.
19. Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H. Nature's TRAIL-on a path to cancer immunotherapy. Immunity 2003;18:1-6.
20. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003;3:46-54.
21. Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35:71-103.
22. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49:4373-84.
23. Stratford IJ, Adams GE, Bremner JC, et al. Manipulation and exploitation of the tumour environment for therapeutic benefit. Int J Radiat Biol 1994;65:85-94.
24. Shinozaki S, Nakamura T, Iimura M, et al. Upregulation of Reg 1α and GW112 in the epithelium of inflamed colonic mucosa. Gut 2001;48:623-9.
25. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-β and retinoic acid combination, using a genetic approach. J Biol Chem 2000;275:33416-26.
26. Fearnley IM, Carroll J, Shannon RJ, Runswick MJ, Walker JE, Hirst J GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH: ubiquinone oxidoreductase (complex I). J Biol Chem 2001;276:38345-8.
27. Chidambaram NV, Angell JE, Ling W, Hofmann ER, Kalvakolanu DV. Chromosomal localization of human GRIM-19, a novel IFN-β and retinoic acid-activated regulator of cell death. J Interferon Cytokine Res 2000;20:661-5.
28. Seo T, Lee D, Shim YS, et al. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM 19, and inhibits interferon/retinoic acid-induced cell death. J Virol 2002;76:8797-807.
29. Lufei C, Ma J, Huang G, et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 2003;22:1325-35.
30. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-14.
31. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998;98:1153-7.
32. Murray JG, Zhang B, Taylor SW, et al. The subunit composition of the human NADH dehydrogenase obtained by rapid one step immunopurification. J Biol Chem 2003;28:28.
33. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57.
34. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Wash DC) 1997;275:1129-32.
35. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-90.
36. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature (Lond) 1997;389:300-5.
37. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999;96:7220-5.
38. Zhan Q, Lord KA, Alamo I, Jr, et al. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol. 1994;14:2361-71.
39. Matsumoto M, Minami M, Takeda K, Sakao Y, Akira S. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett 1996;395:143-7.
40. Maytin EV, Ubeda M, Lin JC, Habener JF. Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res 2001;267:193-204.
41. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001;21:1249-59.
42. Yuan ZM, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R, Kufe D. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Natl Acad Sci USA 1997;94:1437-40.
43. Theis S, Roemer K. c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors. Oncogene 1998;17:557-64.
44. Cong F, Goff SP. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. Proc Natl Acad Sci USA 1999;96:13819-24.
45. Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (Lond) 1999;399:806-9.
46. Yuan ZM, Shioya H, Ishiko T, et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature (Lond) 1999;399:814-7.
47. Sun X, Majumder P, Shioya H, et al. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 2000;275:17237-40.
48. Wang JY. Regulation of cell death by the Abl tyrosine kinase. Oncogene 2000;19:5643-50.
49. Ciavarra RP, Somers KD, Brown RR, et al. Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer. Cancer Res 2000;60:2081-4.
50. Yin XM, Wang K, Gross A, et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature (Lond) 1999;400:886-91.